SEC Form 4 · accession 0001505035-18-000002
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Anne Williams
Officer — SVP, Human Resources
Period of report
Aug 3, 2018
Accepted (ET)
Aug 6, 2018 · 7:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 3, 2018 | S | 293 | $7.20 | D | 196,239 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.
- F2The amount reported includes 1,500 shares of the Issuer's common stock acquired under the GenMark Diagnostics, Inc. Amended and Restated 2013 Employee Stock Purchase Plan since the reporting person last filed a Form 4 with the Securities Exchange Commission.